Sort
40,608 grants matching “prostate cancer”
Molecular Signatures of Lethal an Indolent Prostate Cancer
$398,681Philip W Kantoff · Dana-Farber Cancer Inst · P50 · FY2009 · CA
Molecular Signatures of Lethal an Indolent Prostate Cancer
$398,676Philip W Kantoff · Dana-Farber Cancer Inst · P50 · FY2008 · CA
Signaling importance of âfunctionlessâ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras
$398,657Jing Chen · University Of Chicago · R01 · FY2025 · CA
Epithelial Function in Health and Disease
$398,600Daniel C Marcus · Kansas State University · P20 · FY2009 · RR
Project 2: Near-Infrared Targeted Tracers for Intraoperative Identification of NSCLC
$398,594Philip Stewart Low · University Of Pennsylvania · P01 · FY2024 · CA
MOONSHOT - TOPIC 423 - AN INTEGRATED MULTI-LEVEL DECISION SUPPORT PLATFORM TO ADDRESS PATIENT-CENTERED AND EVIDENCE-BASED SOCIAL DETERMINANTS OF HEALT
$398,555Cupid Chunkin Chan · Pistevo Decision Llc · N43 · FY2021 · CA
Case Comprehensive Cancer Center (Case CCC) Cancer Health Disparities SPORE Planning Grant
$398,550Nathan A. Berger · Case Western Reserve University · P20 · FY2021 · CA
Cancer Genetic Markers of Susceptibility
$398,548Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer
$398,547James M Larner · University Of Virginia · R01 · FY2016 · CA
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end
$398,528Angela H Ting · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA
Novel Degraders of the Androgen Receptor (AR) and AR Splice Variants (AR-SVs)
$398,462Ramesh Narayanan · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy
$398,440Ji-Xin Cheng · Boston University (Charles River Campus) · R33 · FY2021 · CA
STAT Activation: Inactivation Cycle and Activated STAT3 in Cancer Cells
$398,429James E Darnell · Rockefeller University · R01 · FY2010 · AI
Project 1: Modeling tumor evolution in mouse and organoid models
$398,421Raul Rabadan · Columbia University Health Sciences · U54 · FY2017 · CA
Role of BMP and FGF signaling during limb development
$398,410Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mechanism and treatment of PTEN mutant prostate tumorigenesis
$398,400Lloyd C Trotman · Cold Spring Harbor Laboratory · R01 · FY2015 · CA
Mechanism and treatment of PTEN mutant prostate tumorigenesis
$398,400Lloyd C Trotman · Cold Spring Harbor Laboratory · R01 · FY2017 · CA
Mechanism and treatment of PTEN mutant prostate tumorigenesis
$398,400Lloyd C Trotman · Cold Spring Harbor Laboratory · R01 · FY2016 · CA
Mechanism and treatment of PTEN mutant prostate tumorigenesis
$398,400Lloyd C Trotman · Cold Spring Harbor Laboratory · R01 · FY2018 · CA
GREATER DENVER LATINO CANCER PREVENTION/CONTROL NETWORK
$398,399University Of Colorado Denver/Hsc Denver · U01 · FY2003 · CA
Molecular Determinants of Social Factors in Prostate Cancer
$398,386Deepak Kumar · North Carolina Central University · R01 · FY2021 · MD
Molecular Signatures of Lethal an Indolent Prostate Cancer
$398,352Philip W Kantoff · Dana-Farber Cancer Inst · P50 · FY2007 · CA
Defining the non-myogenic origins of pediatric rhabdomyosarcoma
$398,287Mark Edward Hatley · St. Jude Children'S Research Hospital · R01 · FY2019 · CA
Development of small molecules to target KDM4B
$398,287Jun Yang · St. Jude Children'S Research Hospital · R01 · FY2019 · CA
DETERMINANTS OF ESTRAMUSTINE RESISTANCE AND RESPONSE
$398,251Fox Chase Cancer Center · R01 · FY2003 · CA